Cancer BiologyMolecular Cancer TherapeuticsPeer-reviewed
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells
Jerry H. Houl, Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan…·Marie-Claude C. Hofmann
This study identifies a link between the ETV5/p38 signaling axis and aggressive thyroid cancers, showing that combining p38 inhibitors with BRAF inhibitors improves treatment outcomes.
DOI 10.1158/1535-7163.mct-25-0228